Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Rationally Designed Minimal Bioactive Domains of AS-48 Bacteriocin Homologs Possess Potent Antileishmanial Properties

Microbiology Spectrum(2022)10.1128/spectrum.02658-22Source: DataRank Database

Rationally Designed Minimal Bioactive Domains of AS-48 Bacteriocin Homologs Possess Potent Antileishmanial Properties is a research paper published in Microbiology Spectrum (2022). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.00)OA: goldTopics (28)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Jessica Ross ORCID,Francisco R. Fields ORCID,Douglas A. Shoue ORCID,Mary Ann McDowell ORCID,Shaun W. Lee ORCID

Live enrichment

PubMed:36342284 PMC:PMC9769502 OpenAlex:https://openalex.org/W36342284

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: NIH-1DP2OD008468-01

Indiana Clinical and Translational Sciences Institute

Grant: UL1TR002529

HHS | NIH | National Institute of General Medical Sciences

Grant: T32GM075762

NIH HHS

Grant: DP2 OD008468

National Institutes of Health

Grant: 5T32GM075762-12

Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame

National Institutes of Health

Grant: 5UL1TR002529-02

Indiana Clinical and Translational Sciences Institute

National Institutes of Health

Grant: 1DP2OD008468-01

Design and Use of Novel Bacteriocins

FWCI

0.00

Citation Percentile

0.0%

goldLicense: cc-by

publisherhttps://doi.org/10.1128/spectrum.02658-22

publisherhttps://journals.asm.org/doi/pdf/10.1128/spectrum.02658-22

journalhttp://ui.adsabs.harvard.edu/abs/1995euve.prop....6G/abstract

repositoryhttps://doaj.org/article/e52fda037f4e4363ac5869abaea5de5d

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9769502

Fields of Study

Stellar, planetary, and galactic studiesAstronomy and Astrophysical Research0301 basic medicine03 medical and health sciences

MeSH Terms

HumansLeishmania donovaniLeishmaniasisBacteriocinsAntiprotozoal AgentsBridged-Ring Compounds

Keywords

StarsAstrophysicsPhysicsAstronomyLeishmaniaAntimicrobial peptidesBacteriocinsAntileishmanialAntiparasitic AgentsAs-48Bridged-Ring CompoundsAntiprotozoal AgentsMicrobiologyQR1-502HumansLeishmaniasisResearch ArticleLeishmania donovani

Sustainable Development Goals

SDG 3: 3. Good health